GLP-1 Receptor Agonists in Primary Care: What Is Their Place?

Nov 13, 2014

330 likes | 426 Views

GLP-1 Receptor Agonists in Primary Care: What Is Their Place?. Program Goals. ADA/EASD 2012 Recommendations. DURATION 2: Change in HbA 1c at 26 Weeks. DURATION 2: Change in Body Weight at 26 Weeks.

Share Presentation

Embed Code

Link

lucian-rodgers

Download Presentation

GLP-1 Receptor Agonists in Primary Care: What Is Their Place?

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

GLP-1 Receptor Agonists in Primary Care: What Is Their Place?

Program Goals

ADA/EASD 2012 Recommendations

DURATION 2: Change in HbA1c at 26 Weeks
DURATION 2: Change in Body Weight at 26 Weeks

primary care medical home veterans health administration

Primary Care in the Veterans Health Administration. Largest integrated health care system in the countryComprehensive electronic medical record820 sites of Primary Care152 Medical Centers668 Community Based Outpatient Clinics (CBOC)4.5 million primary care patients-each assigned to an individual primary care provider12 million encounters/yearRevisit rate (visits/yr): 2.521% had encounter in Mental Health6.3% had admission5,000 provider FTEE72% physician, 20% Nurse Practitioner, 8% Phy9442

533 views • 14 slides

Primary Care in NHS Grampian

Primary Care in NHS Grampian . By Richard Carey CE, NHSG. Introduction . Policy drivers Local direction setting Why focus on Primary Care? Primary Care – key themes DQPC - Local successes and works in progress Planning The way ahead…. Policy Drivers. Equally Well

486 views • 24 slides

Pharmacology of Cholinergic Agonists

Pharmacology of Cholinergic Agonists. Dr. Thomas Abraham PHAR 417: Fall 2005. Cholinergic Agonists. Parasympathomimetic, cholinoceptor agonists. Have predominant actions on: autonomic effector organs innervated by postganglionic parasympathetic nerves.

1.14k views • 16 slides

Primary Care Renewal in Ontario Focus on Remuneration

Outline. HistoryOntario's goalsPrinciples and elements of primary care renewalThe models and their progressBarriers and facilitators. Ontario's Primary Care Renewal goals are.... Improving access to primary health careIncreasing patient and provider satisfaction with the health care systemImproving quality and continuity of primary health careIncreasing cost-effectiveness of health care services.

748 views • 48 slides

The Role of Primary Care

The Role of Primary Care. Helen Lester , University of Birmingham February 2012. What I’m going to cover. Physical health problems in primary care Primary Care’s attitudes Primary Care’s business. Physical health.

320 views • 14 slides

Primary Care Interface

Primary Care Interface. Julie Crossley. To Discuss . Primary care interface team Productive practice Enhanced service - CCG -Local Authority -NHS England . Primary Care Interface Work Programme. Choose & Book CATS Primary Care Strategy -access, capacity , quality

427 views • 14 slides

Outpatient Services and Primary Health Care

Outpatient Services and Primary Health Care. Heidi Kinsell Manager, Academic Programs Health Services Administration. Overview for Today. Outpatient Care Primary Care What are key issues?. Some Key Terms. Outpatient Services Ambulatory Care Primary Care. Definitions.

537 views • 24 slides

Primary Care Interface Team

Head of Primary Care Interface (Vacant) Overseen by Assoc. Director of Commissioning. Primary Care Interface Manager (Vacant). Primary Care Interface Manager Sharon Woodward . Primary Care Interface Co-ordinator Linda Newton . Primary Care Interface Team .

269 views • 7 slides

Program Goals

Program Goals. Comparison of Incretin-based Agents. Available FDA-Approved GLP-1 Receptor Agonists. GLP-1 Receptor Agonists: Side Effects and Precautions. Reasons for Initiating Insulin Therapy . AACE Glycemic Control Algorithm.

443 views • 17 slides

PRIMARY CARE IN GEORGIA

PRIMARY CARE IN GEORGIA. Hometown Health Annual Conference November 2010. How Important is Primary Care?. An increase of just one primary care physician is associated with 1.44 fewer premature deaths per 10,000 persons

456 views • 23 slides

Primary Care

Primary Care. 2004-2005. Comprehensive Care Clinics. Primary Care. Strategic Plan. T he Ohio State University College of Dentistry aspires to be the nation’s standard setter for education, research, patient care, advocacy and service in the field of oral health. Education. Research.

492 views • 29 slides

Integrating Primary Eye Care and Primary Health Care 17 th Sept 2012

Integrating Primary Eye Care and Primary Health Care 17 th Sept 2012. Dr Padmaja Kumari Rani,M.S,FNB (Retina) Head, Village Vision Complex International Centre for Advancement of Rural Eye Care (ICARE) L V Prasad Eye Institute Hyderabad.

644 views • 32 slides

Revolution in Primary Health Care

Revolution in Primary Health Care. Life Care Centre of Excellence (COE). “Healthy Life Care – Anything Health, Any Place, Any Time”. Oshim Somers esp@oshim.com +61 431 633 375. Commercial in Confidence. Revolution in Primary Health Care. Life Care Centre of Excellence (COE).

250 views • 10 slides

Revolution in Primary Health Care

Revolution in Primary Health Care. Life Care Centre of Excellence (COE ). “Healthy Life Care – Anything Health, Any Place, Any Time”. Oshim Somers esp@oshim.com +61 431 633 375. Commercial in Confidence. Revolution in Primary Health Care. Life Care Centre of Excellence (COE).

274 views • 10 slides

PCR - Primary Care Reform

PCR - Primary Care Reform. “From theory to practice”. What is PrimaCare. The Paris Primary Care Network Signed agreement with Ministry of Health in February 1999, making us the first primary care network. From the Beginning. A complex environment, controversy, political changes

365 views • 18 slides

Cancer Mortality reduction: why it needs action in primary care

Cancer Mortality reduction: why it needs action in primary care. Greg Rubin Professor of General Practice and Primary Care University of Durham. How can primary care contribute?. Early diagnosis Care of survivors Screening. The size of the delay problem. Allgar and Neal, BJ Cancer 2005.

422 views • 21 slides

AUTACOIDS : Receptor- and Non Receptor-Mediated

AUTACOIDS : Receptor- and Non Receptor-Mediated. Therapeutics 201, Learning Unit IV Semester 1, AY 2009-2010 Department of Pharmacology & Toxicology UP College of Medicine July 13, 2009. Autacoids : Agonists, Antagonists. Objectives: At the end of the session, students are expected to:

1.66k views • 98 slides

Cholinergic agonists & Cholinergic antagonists Adrenergic agonists & Adrenergic antagonists

Cholinergic agonists & Cholinergic antagonists Adrenergic agonists & Adrenergic antagonists. Part I. Cholinergic agonists. 1. direct cholinergic agonists 2. cholinesterase inhibitors .

981 views • 29 slides

Primary Care/Specialty Care in the Era of Multimorbidity

Primary Care/Specialty Care in the Era of Multimorbidity. Barbara Starfield, MD, MPH EUROPEAN FORUM FOR PRIMARY CARE Pisa, Italy: August 30-31, 2010. United States $7,290. The Cost of Care.

1.05k views • 67 slides

Chapter 7: Outpatient Services and Primary Care

Chapter 7: Outpatient Services and Primary Care. Lecturer: Monika M. Wahi , MPH, CPH. Learning Objectives. Give an example of a health outcome which is improved in a population with good access to primary care Name and describe one of the domains of primary care

2.71k views • 38 slides

Secondary Hyperparathyroidism in CKD: Usefulness of VDR Agonists

Secondary Hyperparathyroidism in CKD: Usefulness of VDR Agonists. Reference: Sprague SM, Coyne D. Control of secondary hyperparathyroidism by vitamin d receptor agonists in chronic kidney disease. Clin J Am Soc Nephrol . 2010;5:512–518. Introduction: SHPT in CKD.

411 views • 11 slides

More Related

GLP-1 Receptor Agonists in Primary Care: What Is Their Place?

GLP-1 Receptor Agonists in Primary Care: What Is Their Place?

Presentation Transcript

primary care medical home veterans health administration

Primary Care in NHS Grampian

Pharmacology of Cholinergic Agonists

Primary Care Renewal in Ontario Focus on Remuneration

The Role of Primary Care

Primary Care Interface

Outpatient Services and Primary Health Care

Primary Care Interface Team

Program Goals

PRIMARY CARE IN GEORGIA

Primary Care

Integrating Primary Eye Care and Primary Health Care 17 th Sept 2012

Revolution in Primary Health Care

Revolution in Primary Health Care

PCR - Primary Care Reform

Cancer Mortality reduction: why it needs action in primary care

AUTACOIDS : Receptor- and Non Receptor-Mediated

Cholinergic agonists &amp; Cholinergic antagonists Adrenergic agonists &amp; Adrenergic antagonists

Primary Care/Specialty Care in the Era of Multimorbidity

Chapter 7: Outpatient Services and Primary Care

Secondary Hyperparathyroidism in CKD: Usefulness of VDR Agonists

Cholinergic agonists & Cholinergic antagonists Adrenergic agonists & Adrenergic antagonists